Menarini Ricerche S.P.A.
Records under this name other than patents Menarini Ricerche S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Menarini Ricerche S.P.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,864,366 | Process for the preparation of (e)-5-(2-bromovinyl)-2′-deoxyuridine Term ended Term ended Feb 21, 2022 · USPTO record | Term ended | Term ended Feb 21, 2022 | USPTO record |
| US 6,921,841 | Process for the synthesis of optically active anthracyclines Term ended Term ended Nov 15, 2021 · USPTO record | Term ended | Term ended Nov 15, 2021 | USPTO record |
| US 7,491,825 | Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom Lapsed on the fee record Ended Feb 17, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 17, 2021 | USPTO record |
| US 7,273,856 | Linear basic compounds having NK-2 antagonist activity and formulations thereof Lapsed on the fee record Ended Sep 25, 2019 · USPTO record | Lapsed on the fee record | Ended Sep 25, 2019 | USPTO record |
| US 7,999,068 | Process for the preparation of bicyclic peptide compounds Lapsed on the fee record Ended Aug 16, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 16, 2019 | USPTO record |
| US 6,521,760 | Process for the preparation of zofenopril calcium salt Formerly held Lapsed on the fee record Ended Feb 18, 2015 · USPTO record | Lapsed on the fee record | Ended Feb 18, 2015 | USPTO record |
| US 6,515,012 | Process for the preparation of zofenopril calcium salt Formerly held Lapsed on the fee record Ended Feb 4, 2015 · USPTO record | Lapsed on the fee record | Ended Feb 4, 2015 | USPTO record |
| US 7,015,196 | Basic monocyclic compounds having Nk2 antagonist action, processes for their preparation, and formulations containing them Lapsed on the fee record Ended Mar 21, 2010 · USPTO record | Lapsed on the fee record | Ended Mar 21, 2010 | USPTO record |
| US 6,780,968 | Monocyclic compounds with four bifunctional residues having NK-2 antagonist action Lapsed on the fee record Ended Aug 24, 2008 · USPTO record | Lapsed on the fee record | Ended Aug 24, 2008 | USPTO record |
| US 6,653,289 | L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them Lapsed on the fee record Ended Nov 25, 2007 · USPTO record | Lapsed on the fee record | Ended Nov 25, 2007 | USPTO record |